
ESC 2026 marked a turning point — GLP-1s earn their first formal heart failure guideline recommendation and become a cardiometabolic platform.
Learn how pharma leaders are using coaching to boost field performance, reinforce compliance, and deliver better HCP and patient outcomes - from onboarding to autonomy.